Top-News

Novo-Nordisk Aktie (ADR) News

Aktie
WKN:  866931 ISIN:  US6701002056 US-Symbol:  NVO Branche:  Pharmazeutika Land:  Dänemark
42,15 €
+0,90 €
+2,18%
12:25:27 Uhr
Depot/Watchlist
Marktkapitalisierung *
139,95 Mrd. €
Streubesitz
89,76%
KGV
27,28
Dividende
0,58 $
Dividendenrendite
1,23%
Faktor
1
Originalaktie
DK0062498333
Weiter aufwärts? Long handeln - Jetzt mit Hebel 6,25: UQ31DT
Werbung

Novo-Nordisk Aktie (ADR) News

23.09.25 - inv3st.de
Was MASH aus Ihrem Depot machen kann: BioNxt, Roche, Novo Nordisk
Haben Sie schon einmal von MASH gehört? Was in aller Kürze für metabolisch assoziierte Steatohepatitis steht, hat man früher schlicht „Fettleber“ genannt. Medikamente gegen die ...
22.09.25 - PR Newswire
DEADLINE APPROACHING: Berger Montague Advises Nordisk A/S (NYSE: NVO) Investors to Inquire About a Securities Fraud Class Action by September 30, 2025
DEADLINE APPROACHING: Berger Montague Advises Nordisk A/S (NYSE: NVO) Investors to Inquire About a Securities Fraud Class Action by September 30, 2025 PR Newswire
22.09.25 - PR Newswire
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before September 30, 2025 to Discuss Your Rights - NVO
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before September 30, 2025 to Discuss Your Rights - NVO PR Newswire
22.09.25 - PR Newswire
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
19.09.25 - PR Newswire
Investors who lost money on Novo Nordisk A/S(NVO) should contact Levi & Korsinsky about pending Class Action - NVO
Investors who lost money on Novo Nordisk A/S(NVO) should contact Levi & Korsinsky about pending Class Action - NVO PR Newswire
19.09.25 - LYNX Analysen
Novo Nordisk: Trendwende möglich?
Novo Nordisk zeigt nach positiven Nachrichten zur Abnehm-​Pille eine technische Erholung. Kann die Aktie diesen Schwung nutzen? Jetzt vollständige Analyse lesen
18.09.25 - PR Newswire
Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 - NVO
Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 - NVO PR Newswire
18.09.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO PR ...
18.09.25 - PR Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 30, 2025 in Novo Lawsuit - NVO
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 30, 2025 in Novo Lawsuit - NVO PR Newswire
17.09.25 - PR Newswire
NVO Deadline: NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
NVO Deadline: NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit PR Newswire
17.09.25 - PR Newswire
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
17.09.25 - PR Newswire
NOVO NORDISK A/S (NYSE: NVO) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by September 30, 2025
NOVO NORDISK A/S (NYSE: NVO) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by September ...
16.09.25 - PR Newswire
Levi & Korsinsky Notifies Shareholders of Novo Nordisk A/S(NVO) of a Class Action Lawsuit and an Upcoming Deadline
Levi & Korsinsky Notifies Shareholders of Novo Nordisk A/S(NVO) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire
15.09.25 - PR Newswire
Investors who lost money on Novo Nordisk A/S(NVO) should contact The Gross Law Firm about pending Class Action - NVO
Investors who lost money on Novo Nordisk A/S(NVO) should contact The Gross Law Firm about pending Class Action - NVO PR Newswire
13.09.25 - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk PR Newswire
13.09.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO PR ...
12.09.25 - PR Newswire
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
11.09.25 - PR Newswire
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit PR Newswire
11.09.25 - PR Newswire
September 30, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVO
September 30, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVO PR Newswire
09.09.25 - PR Newswire
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +0,36%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »